StockData

Nu-Med Plus, Inc. (NUMD) stock

NUMDOTCGold and Silver OresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.01−0.00 (-8.16%)

Close on Oct 19, 2026Market cap $601.55KP/E –Yield –

Nu-Med Plus net income

Net income is the profit left for shareholders after every expense, interest and tax.

Nu-Med Plus's net income for the twelve months ending Jun 30, 2026 was -$20.79K. For fiscal 2025 it was -$56.18K. The highest annual figure on record is $9.65M in fiscal 2016.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$56.18K–
FY2024Dec 31, 2024-$68.35K–
FY2023Dec 31, 2023-$125.53K–
FY2022Dec 31, 2022-$130.17K–
FY2021Dec 31, 2021-$830.06K–
FY2020Dec 31, 2020-$2.01M–
FY2019Dec 31, 2019-$1.04M–
FY2018Dec 31, 2018-$1.19M-133.2%
FY2017Dec 31, 2017$3.58M-62.9%
FY2016Dec 31, 2016$9.65M–
FY2015Dec 31, 2015-$8.88M–
FY2014Dec 31, 2014-$1.19M–
FY2013Dec 31, 2013-$332.29K–
FY2012Dec 31, 2012-$262.74K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$19.67K–
Q1 FY2026Mar 31, 2026-$15.88K–
Q4 FY2025Dec 31, 2025-$12.62K–
Q3 FY2025Sep 30, 2025-$11.97K–
Q2 FY2025Jun 30, 2025-$11.67K–
Q1 FY2025Mar 31, 2025-$19.93K–
Q4 FY2024Dec 31, 2024-$10.56K–
Q3 FY2024Sep 30, 2024-$18.68K–
Q2 FY2024Jun 30, 2024-$17.29K–
Q1 FY2024Mar 31, 2024-$21.83K–
Q4 FY2023Dec 31, 2023-$56.60K-232.8%
Q3 FY2023Sep 30, 2023-$16.41K–
Q2 FY2023Jun 30, 2023-$24.32K–
Q1 FY2023Mar 31, 2023-$28.20K–
Q4 FY2022Dec 31, 2022$42.61K–
Q3 FY2022Sep 30, 2022-$58.05K–
Q2 FY2022Jun 30, 2022-$58.07K–
Q1 FY2022Mar 31, 2022-$56.65K–
Q4 FY2021Dec 31, 2021-$112.34K–
Q3 FY2021Sep 30, 2021-$118.37K–
Q2 FY2021Jun 30, 2021-$242.61K–
Q1 FY2021Mar 31, 2021-$356.75K–
Q4 FY2020Dec 31, 2020-$493.37K–
Q3 FY2020Sep 30, 2020-$453.82K–
Q2 FY2020Jun 30, 2020-$908.47K–
Q1 FY2020Mar 31, 2020-$153.33K–
Q4 FY2019Dec 31, 2019-$209.87K–
Q3 FY2019Sep 30, 2019-$150.58K–
Q2 FY2019Jun 30, 2019-$248.18K–
Q1 FY2019Mar 31, 2019-$428.20K–
Q4 FY2018Dec 31, 2018-$340.96K–
Q3 FY2018Sep 30, 2018-$526.85K-113.2%
Q2 FY2018Jun 30, 2018-$173.56K–
Q1 FY2018Mar 31, 2018-$147.49K–
Q2 FY2017Jun 30, 2017-$116.05K–
Q1 FY2017Mar 31, 2017$3.99M–

More Nu-Med Plus figures

See a number that looks wrong?